SABS
SAB Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
SABS fundamentals
SAB Biotherapeutics (SABS) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -1.09 (YoY -37.97%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-1.09
-37.97%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
SAB Biotherapeutics (SABS) key financial stats and ratios, covering profitability, financial health, and leverage.
SAB Biotherapeutics (SABS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
SAB Biotherapeutics (SABS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
SAB Biotherapeutics (SABS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does SAB Biotherapeutics (SABS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track SAB Biotherapeutics (SABS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did SAB Biotherapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for SAB Biotherapeutics next quarter?What is SAB Biotherapeutics's latest dividend and current dividend yield?What guidance did SAB Biotherapeutics's management provide for the next earnings period?What factors drove the changes in SAB Biotherapeutics's revenue and profit?What were the key takeaways from SAB Biotherapeutics’s earnings call?What were the key takeaways from SAB Biotherapeutics's earnings call?What does SAB Biotherapeutics do and what are its main business segments?
